Document Detail

Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro.
MedLine Citation:
PMID:  17206477     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: During intraoperative hyperthermic intraperitoneal chemotherapy for primary or secondary peritoneal malignancies, tumor cells are exposed to high drug concentrations for a relatively short period of time. We investigated in vitro the effect of paclitaxel and hyperthermia on cell proliferation, cell cycle kinetics and cell death under conditions resembling those during intraoperative hyperthermic intraperitoneal chemotherapy. METHODS: Human breast MCF-7, ovarian SKOV-3 and hepatocarcinoma HEpG2 cells were exposed to 10 and 20 microM paclitaxel at 37, 41.5 or 43 degrees C for 2 h. Cell proliferation, cell cycle kinetics, necrosis and apoptosis were evaluated. RESULTS: Hyperthermia exerted a cytostatic effect to all cell lines and at 43 degrees C a cytotoxic effect on MCF-7 cells. MCF-7 and SKOV-3 cells treated under normothermic conditions with paclitaxel were arrested at G2/M or M phase for at least 3 days. Most of MCF-7 cells and approximately half of SKOV-3 cells were in interphase and became multinucleated without properly completing cytokinesis. Hyperthermia at 41.5 degrees C altered cell cycle distribution and affected the paclitaxel-related effect on cell cycle kinetics of MCF-7 and SKOV-3 cells. Analysis of the mode of cell death showed that cell necrosis prevailed over apoptosis. Hyperthermia at 43 degrees C increased paclitaxel-mediated cytotoxicity in MCF-7 cells and to a lesser extent in SKOV-3 and HEpG2 cells. CONCLUSIONS: Short-time treatment of carcinoma cells with high (micromolar) concentrations of paclitaxel in normothermic and hyperthermic conditions is highly efficient for cell growth arrest and could be of clinical relevance in locoregional chemotherapy.
John Michalakis; Spyros D Georgatos; Eelco de Bree; Hara Polioudaki; John Romanos; Vassilis Georgoulias; Dimitris D Tsiftsis; Panayiotis A Theodoropoulos
Related Documents :
21372207 - Type viii collagen modulates tgf-β1-induced proliferation of mesangial cells.
2645297 - Cell cycle-dependent association of hsp70 with specific cellular proteins.
6929387 - Stable heat-resistant variants in populations of chinese hamster cells.
13707 - Mating reaction in saccharomyces cerevisiae. x. agglutinability-inactivating factor: a ...
24662787 - Influence of betulin and 28-o-propynoylbetulin on proliferation and apoptosis of human ...
20066077 - Physical model of cellular symmetry breaking.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-01-07
Journal Detail:
Title:  Annals of surgical oncology     Volume:  14     ISSN:  1068-9265     ISO Abbreviation:  Ann. Surg. Oncol.     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-03-09     Completed Date:  2007-06-12     Revised Date:  2007-07-18    
Medline Journal Info:
Nlm Unique ID:  9420840     Medline TA:  Ann Surg Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1220-8     Citation Subset:  IM    
Department of Biochemistry, School of Medicine, University of Crete, P.O. Box 2208, 71003, Heraklion, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents, Phytogenic / pharmacology*
Apoptosis / drug effects*
Breast Neoplasms / metabolism,  therapy
Carcinoma, Hepatocellular / metabolism,  therapy
Cell Cycle / drug effects*
Cell Proliferation / drug effects*
Liver Neoplasms / metabolism,  therapy
Neoplasms / metabolism,  therapy*
Ovarian Neoplasms / metabolism,  therapy
Paclitaxel / pharmacology*
Tumor Cells, Cultured
Reg. No./Substance:
0/Antineoplastic Agents, Phytogenic; 33069-62-4/Paclitaxel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Frequent but borderline methylation of p16 (INK4a) and TIMP3 in medulloblastoma and sPNET revealed b...
Next Document:  Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemoth...